Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
Menon
K N
KN
Seshadri
M S
MS
D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D004359:Drug Therapy, Combination; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D007328:Insulin; D013453:Sulfonylurea Compounds